BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 28948688)

  • 1. Serially measured circulating microRNAs and adverse clinical outcomes in patients with acute heart failure.
    van Boven N; Kardys I; van Vark LC; Akkerhuis KM; de Ronde MWJ; Khan MAF; Merkus D; Liu Z; Voors AA; Asselbergs FW; van den Bos EJ; Boersma E; Hillege H; Duncker DJ; Pinto YM; Postmus D
    Eur J Heart Fail; 2018 Jan; 20(1):89-96. PubMed ID: 28948688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating microRNA-150-5p as a novel biomarker for advanced heart failure: A genome-wide prospective study.
    Scrutinio D; Conserva F; Passantino A; Iacoviello M; Lagioia R; Gesualdo L
    J Heart Lung Transplant; 2017 Jun; 36(6):616-624. PubMed ID: 28259597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of circulating microRNAs on heart failure-related morbidity and mortality in two large diverse cohorts of general heart failure patients.
    Bayés-Genis A; Lanfear DE; de Ronde MWJ; Lupón J; Leenders JJ; Liu Z; Zuithoff NPA; Eijkemans MJC; Zamora E; De Antonio M; Zwinderman AH; Pinto-Sietsma SJ; Pinto YM
    Eur J Heart Fail; 2018 Jan; 20(1):67-75. PubMed ID: 28949058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating miR-19b-3p as a Novel Prognostic Biomarker for Acute Heart Failure.
    Su Y; Sun Y; Tang Y; Li H; Wang X; Pan X; Liu W; Zhang X; Zhang F; Xu Y; Yan C; Ong SB; Xu D
    J Am Heart Assoc; 2021 Oct; 10(20):e022304. PubMed ID: 34612058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating microRNA-132 levels improve risk prediction for heart failure hospitalization in patients with chronic heart failure.
    Masson S; Batkai S; Beermann J; Bär C; Pfanne A; Thum S; Magnoli M; Balconi G; Nicolosi GL; Tavazzi L; Latini R; Thum T
    Eur J Heart Fail; 2018 Jan; 20(1):78-85. PubMed ID: 29027324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serially measured circulating miR-22-3p is a biomarker for adverse clinical outcome in patients with chronic heart failure: The Bio-SHiFT study.
    van Boven N; Akkerhuis KM; Anroedh SS; Rizopoulos D; Pinto Y; Battes LC; Hillege HL; Caliskan KC; Germans T; Manintveld OC; Cornel JH; Constantinescu AA; Boersma E; Umans VA; Kardys I
    Int J Cardiol; 2017 May; 235():124-132. PubMed ID: 28274577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Value of Serial ST2 Measurements in Patients With Acute Heart Failure.
    van Vark LC; Lesman-Leegte I; Baart SJ; Postmus D; Pinto YM; Orsel JG; Westenbrink BD; Brunner-la Rocca HP; van Miltenburg AJM; Boersma E; Hillege HL; Akkerhuis KM;
    J Am Coll Cardiol; 2017 Nov; 70(19):2378-2388. PubMed ID: 29096809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating microRNAs in heart failure with reduced and preserved left ventricular ejection fraction.
    Wong LL; Armugam A; Sepramaniam S; Karolina DS; Lim KY; Lim JY; Chong JP; Ng JY; Chen YT; Chan MM; Chen Z; Yeo PS; Ng TP; Ling LH; Sim D; Leong KT; Ong HY; Jaufeerally F; Wong R; Chai P; Low AF; Lam CS; Jeyaseelan K; Richards AM
    Eur J Heart Fail; 2015 Apr; 17(4):393-404. PubMed ID: 25619197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating microRNAs and Outcome in Patients with Acute Heart Failure.
    Seronde MF; Vausort M; Gayat E; Goretti E; Ng LL; Squire IB; Vodovar N; Sadoune M; Samuel JL; Thum T; Solal AC; Laribi S; Plaisance P; Wagner DR; Mebazaa A; Devaux Y;
    PLoS One; 2015; 10(11):e0142237. PubMed ID: 26580972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating microRNAs as candidate markers to distinguish heart failure in breathless patients.
    Ellis KL; Cameron VA; Troughton RW; Frampton CM; Ellmers LJ; Richards AM
    Eur J Heart Fail; 2013 Oct; 15(10):1138-47. PubMed ID: 23696613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low circulating microRNA levels in heart failure patients are associated with atherosclerotic disease and cardiovascular-related rehospitalizations.
    Vegter EL; Ovchinnikova ES; van Veldhuisen DJ; Jaarsma T; Berezikov E; van der Meer P; Voors AA
    Clin Res Cardiol; 2017 Aug; 106(8):598-609. PubMed ID: 28293796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating microRNAs as novel biomarkers for heart failure.
    Chen F; Yang J; Li Y; Wang H
    Hellenic J Cardiol; 2018; 59(4):209-214. PubMed ID: 29126951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic and prognostic value of plasma miR-106a-5p levels in patients with acute heart failure.
    Fei A; Li L; Li Y; Zhou T; Liu Y
    J Cardiothorac Surg; 2024 Apr; 19(1):261. PubMed ID: 38654254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of circulating microRNAs in patients with repaired Tetralogy of Fallot with and without heart failure.
    Abu-Halima M; Meese E; Keller A; Abdul-Khaliq H; Rädle-Hurst T
    J Transl Med; 2017 Jul; 15(1):156. PubMed ID: 28693530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Signature of circulating microRNAs in patients with acute heart failure.
    Ovchinnikova ES; Schmitter D; Vegter EL; Ter Maaten JM; Valente MA; Liu LC; van der Harst P; Pinto YM; de Boer RA; Meyer S; Teerlink JR; O'Connor CM; Metra M; Davison BA; Bloomfield DM; Cotter G; Cleland JG; Mebazaa A; Laribi S; Givertz MM; Ponikowski P; van der Meer P; van Veldhuisen DJ; Voors AA; Berezikov E
    Eur J Heart Fail; 2016 Apr; 18(4):414-23. PubMed ID: 26345695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of biomarkers to establish potential role and function of circulating microRNAs in acute heart failure.
    Vegter EL; Schmitter D; Hagemeijer Y; Ovchinnikova ES; van der Harst P; Teerlink JR; O'Connor CM; Metra M; Davison BA; Bloomfield D; Cotter G; Cleland JG; Givertz MM; Ponikowski P; van Veldhuisen DJ; van der Meer P; Berezikov E; Voors AA; Khan MA
    Int J Cardiol; 2016 Dec; 224():231-239. PubMed ID: 27661412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triple head-to-head comparison of fibrotic biomarkers galectin-3, osteopontin and gremlin-1 for long-term prognosis in suspected and proven acute heart failure patients.
    Behnes M; Bertsch T; Weiss C; Ahmad-Nejad P; Akin I; Fastner C; El-Battrawy I; Lang S; Neumaier M; Borggrefe M; Hoffmann U
    Int J Cardiol; 2016 Jan; 203():398-406. PubMed ID: 26539964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating miR-23b-3p, miR-145-5p and miR-200b-3p are potential biomarkers to monitor acute pain associated with laminitis in horses.
    Lecchi C; Dalla Costa E; Lebelt D; Ferrante V; Canali E; Ceciliani F; Stucke D; Minero M
    Animal; 2018 Feb; 12(2):366-375. PubMed ID: 28689512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating MicroRNA-423-3p Improves the Prediction of Coronary Artery Disease in a General Population - Six-Year Follow-up Results From the China-Cardiovascular Disease Study.
    Wang X; Dong Y; Fang T; Wang X; Chen L; Zheng C; Kang Y; Jiang L; You X; Gai S; Wang Z; Cao H
    Circ J; 2020 Jun; 84(7):1155-1162. PubMed ID: 32404537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between admission plasma 2-oxoglutarate levels and short-term outcomes in patients with acute heart failure: a prospective cohort study.
    Peng Z; Zhan Q; Xie X; Li H; Tu Y; Bai Y; Huang X; Lai W; Zhao B; Zeng Q; Xu D
    Mol Med; 2019 Mar; 25(1):8. PubMed ID: 30922225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.